Diagnostic testing for the new coronavirus strain COVID-19 can be carried out through molecular analysis or by ELISA. In the United States, the CDC employs molecular test methodologies to diagnose active infections and serology antibody testing for surveillance and investigational purposes. The main advantages of RT-qPCR are the speed, sensitivity and ability to detect transmission of the disease very early on in the course of infection. However, since antibodies continue to circulate after an infection has cleared, serology tests are useful tools for monitoring the evolution of an outbreak and for identifying previously undiagnosed infections in the asymptomatic population.
Meridian offers a range of COVID-19 testing solutions for both molecular and immunoassay technologies. From optimized RT-qPCR mixes ideal for fast and accurate molecular testing through to high performing recombinant antigens for IgG and/or Igm testing, we have your needs covered.
Request more information!